Hodgkin Lymphoma PDQ®

In brief

Evidence-based clinical reference from the National Cancer Institute for healthcare professionals managing childhood Hodgkin lymphoma. Provides current treatment protocols, risk stratification approaches, and therapeutic strategies for this pediatric hematologic malignancy.

• Hodgkin lymphoma is a highly curable pediatric malignancy with distinct treatment protocols for children versus adults.
• Risk-adapted therapy balances cure rates with minimizing long-term toxicities including secondary malignancies and cardiac disease.
• PET-CT imaging is critical for staging and response assessment to guide treatment intensity.
• Combined modality therapy (chemotherapy + radiation) remains standard, though radiation doses have been reduced to limit late effects.
• Long-term survivorship care is essential given risks of secondary cancers, cardiovascular disease, and endocrine dysfunction.

Written by the GCMD Library team from the guideline.